Halifax, Canada · Founded 2012 · Privately Held (backing)
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.
Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$121.7M
Last round
Seed Round
Oct 2025
Team — not yet on record
No current team members for ABK Biomedical are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ABK Biomedical with a free account
·The complete investor list: 11 names
·Watch ABK Biomedical: the Monday email on marks, rounds and moves
